Relevant bibliographies by topics / Mycosis

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Mycosis'

Author: Grafiati
Published: 4 June 2021
Last updated: 15 June 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Mycosis.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Mycosis"

1

Sakaniya, L. R., and I. M. Korsunskaya. "Foot mycosis: how to help active patients." Meditsinskiy sovet = Medical Council, no. 12 (October 7, 2020): 24–27. http://dx.doi.org/10.21518/2079-701x-2020-12-24-27.

Full text
Abstract:
Mycotic infections of the feet are common fungal infections in our time. According to some reports, about 10% of the world's population suffer from these infections. Men suffer from foot mycosis more often than others. Foot mycosis can manifest itself in three clinical forms: interdigital, plantar and vesiculopapular. Foot mycosis is often combined with onychomycosis or becomes a risk factor for its development. Many diseases, such as diabetes mellitus, vascular diseases, obesity are risk factors for foot mycosis. But what is important is that young and middle-aged people who lead an active lifestyle are at risk. It has long been established that public places such as gyms, swimming pools, baths and saunas are a source of mycotic infections. The internal climatic environment of footwear also has a significant impact on the development of foot mycosis. Closed shoes with high internal temperature and humidity create ideal conditions for dermatophyte growth. That is why people who prefer closed, even cloth shoes, or office workers, who are forced to constantly wear closed shoes, often suffer from foot mycosis and other fungal infections.The main problem in the treatment of foot mycoses is adherence to the prescribed treatment. In our practice, mycotic lesions are more common in people who lead an active lifestyle and are unable to adhere to a long course of therapy. Indeed, the treatment of mycosis often involves a two-week application of some topical antifungal agent. It is optimal to prescribe a single application of terbinafine film forming solution to such patients. This drug ensures the clinical effectiveness of therapy as it keeps antifungi-cidal activity for 13 days from the date of application and high adherence to treatment.
APA, Harvard, Vancouver, ISO, and other styles
2

Yakovlev, A. В. "Issues of stage-by-stage approach to the external therapy of foot skin mycosis." Medical Council, no. 21 (January 20, 2019): 146–51. http://dx.doi.org/10.21518/2079-701x-2018-21-146-151.

Full text
Abstract:
Foot skin mycosis is one of the most topical problems in dermatovenerology due to the extreme prevalence of these diseases. Treatment of foot skin mycoses is the most important step in the prevention of onychomycosis. The tactics and a specific sequence of the external therapy depends on the specific clinical form of mycosis: acute inflammatory forms require the prescription of solutions and gels, subacute forms required creams, chronic forms require adhesive agents. Exudative form of the foot skin mycosis with vesiculation is an indication for the combination therapy.
APA, Harvard, Vancouver, ISO, and other styles
3

Nakhli, Raja, Mohamed Sbai, Salma Rouhi, Redouane Moutaj, and El Mostafa El Mezouari. "Superficial Mycosis at the Avicenne Military Hospital in Marrakesh: 5-Years Review." Saudi Journal of Medicine 7, no. 1 (2022): 52–56. http://dx.doi.org/10.36348/sjm.2022.v07i01.009.

Full text
Abstract:
Superficial mycosis were diagnosed in 1231 cases, a prevalence of 62.07%. The average age of the patients was 45 years, the sex ratio M/F was 1.19. The majority of the patients were followed as outpatients (96.99%). Of all superficial mycosis, onychomycosis was the most frequent with a rate of 52.32%, followed by epidermomycosis (37.44%), scalp mycosis (8.37%), oral mycosis (1.71%) and genital mycosis (0.16%). Dermatophytes were the most isolated (85.05%), followed by yeasts (13.65%), molds (1.30%). The main dermatophytic species were represented by Trichophyton rubrum (80.99%), followed by Trichophyton mentagrophytes var. interdigitale (8.88%) and Microsporum canis (6.59%). The most common yeasts found were Candida albicans (67.86%), followed by Malassezia furfur (22.02%). Scopulariopsis brevicaulis was the most isolated mold (68.75%). At the end of this study we conclude that mycological examination is essential in the management of patients with superficial mycoses; which must also include the elimination of favourable factors in order to avoid recurrence.
APA, Harvard, Vancouver, ISO, and other styles
4

Kubanova, A. A., N. V. Kozhichkina, A. A. Kubanova, and N. V. Kozhichkina. "Binafin in treatment of nail mycosis." Vestnik dermatologii i venerologii 86, no. 3 (2010): 70–74. http://dx.doi.org/10.25208/vdv850.

Full text
Abstract:
The article presents the results of a direct open-label study of the efficacy and safety of BINAFIN® for treatment of foot and hand nail mycoses in 30 patients. Patients were administered one pill (250 mg) of BINAFIN® a day on a daily basis for 3-5 months. Clinical and anti-mycosis efficacy was achieved in 92.6% cases of foot and hand nail mycoses.
APA, Harvard, Vancouver, ISO, and other styles
5

Thomas, P. A. "Mycotic keratitis — an underestimated mycosis." Medical Mycology 32, no. 4 (1994): 235–56. http://dx.doi.org/10.1080/02681219480000321.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Akhmedova, S. D. "Retrospective analysis of the superficial dermatomycosis prevalence in areas of the Greater Caucasus of Azerbaijan." Kazan medical journal 96, no. 6 (2015): 1038–42. http://dx.doi.org/10.17750/kmj2015-1038.

Full text
Abstract:
Aim. Study the epidemiological situation regarding the prevalence of skin, hair or nails superficial mycoses in 15 districts of the Greater Caucasus of Azerbaijan for the period from 2000 to 2012. Methods. Such indicators as the number of patient visits, periodic screening examinations and admissions were analyzed using the current and archived medical records of the Municipal Center for Skin and Sexually transmitted diseases №1, Republican Center for Skin and Sexually transmitted diseases, Republican Paediatric Center for Skin and Sexually transmitted diseases №3 of the Azerbaijan Republic. Skin superficial mycoses were diagnosed after laboratory (microscopic) verification of fungal mycelium presence. Intensive indicators were calculated, such as the prevalence of skin superficial mycoses and the number of patient visits due to skin superficial mycoses. Results. The prevalence of the skin superficial mycoses has increased in the Greater Caucasus of Azerbaijan area at the examined period (2000 to 2012) since 2004, with the prevalence peaks in 2007, 2009 and 2011. Men were twice (61.54%) more commonly affected compared to women (38.06%). The highest prevalence of skin superficial mycoses was registered in age groups of 0-10 (38.69%) and 11-20 (20.83%) years, the main diagnosis were «scalp mycosis» (27.98%) and «tinea versicolor» (22.62%). The prevalence of skin candidiasis (1.19±0.84%), onychomycosis (4.17±1.54%), tinea cruris (5.36±1.74%), combined scalp and glabrous skin mycosis (5.95±1.83%), athlete’s foot (8.93±2.20%), «Kerion» lesions (10.71±2.39%), glabrous skin mycosis (13.10±2.60%) increased. The prevalence of skin superficial mycoses was the highest in 2011 - 1.980±0.388%, the number of patient visits due to skin superficial mycoses - 0.712±0.140%; in 2007 the following numbers were 1.911±0.390% and 0.607±0.124% respectively, in 2009 - 1.637±0.357% and 0.537±0.117%, duplicating the prevalence peaks. High prevalence of superficial dermatomycoses was seen in Khizi and Ismailli Districts, the lowest - in Balakan, Qusar, Oghuz, Shaki Districts. Conclusions. In the current social and economic conditions, the system of complex examination (cultures, microscopy) of patients with skin mycoses is required, as well as the program of targeted preventive measures and improvement of medical and social aid management.
APA, Harvard, Vancouver, ISO, and other styles
7

Reshetnikova, V. P., L. A. Baryshevskaya, O. V. Zeleva, and M. N. Popov. "DIAGNOSTICS OF PHARYNX MYCOSIS." Science and Innovations in Medicine 3, no. 1 (2018): 22–25. http://dx.doi.org/10.35693/2500-1388-2018-0-1-22-25.

Full text
Abstract:
Aim - to characterize different methods for diagnosis of mycotic lesions of the pharynx used in medical practice. Materials and methods. This article describes various methods of laboratory diagnostics of tonsillopharyngeal mycosis and their indications; and presents the analysis of 117 adult cases of tonsillopharyngeal mycosis confirmed by the analysis of thick blood film after the incubation in thermoregulator combined with blood agar inoculation. In addition, this method includes a microflora test which in most chronical cases accompanies pharyngeal mycosis. Results. The study revealed relevant advantages of the presented methods of pharynx mycosis diagnostics, which not only detect the presence of mycelium and its morphology, but also evaluate its role in the inflammatory process. In addition, this method includes bacterial culture test that in most chronical cases accompanies pharynx mycosis. Out of 100% only 17.9% of observations (21 patients) showed Candida fungus in parasitic phase as mono-infection, the other 82.1% of cases proved bacterial presence. The most frequent combination was Candida and Streptococcus spp (including pneumococcus) that made up 41.9% of total observations. In 10.3% of cases Staphylococcus spp was detected. Other patients had more than two kinds of microorganisms. The following combinations were revealed: fungi, streptococci and staphylococci in 17.9% cases; fungi and streptococci with Klebsiella and\or Moraxella catarrhalis or other opportunistic pathogenic microflora in 12% cases. Conclusions. The most effective method of research of upper airway mycosis is the one that enables to reveal Candida fungi presence and concentration as well as to identify their status (saprophitic or parasitic) in the patient's body using thick blood microscopy. The value of this method increases with simultaneous evaluation of associated microflora and its relation to macroorganism. Being simple, cost-effective and highly informative, complex method of diagnostics of upper airway mycosis can be widely used in medical practice.
APA, Harvard, Vancouver, ISO, and other styles
8

Yamazaki, Toshikazu, Hikaru Kume, Setsuko Murase, Eriko Yamashita, and Mikio Arisawa. "Epidemiology of Visceral Mycoses: Analysis of Data in Annual of the Pathological Autopsy Cases in Japan." Journal of Clinical Microbiology 37, no. 6 (1999): 1732–38. http://dx.doi.org/10.1128/jcm.37.6.1732-1738.1999.

Full text
Abstract:
The data on visceral mycoses that had been reported in theAnnual of the Pathological Autopsy Cases in Japan from 1969 to 1994 by the Japanese Society of Pathology were analyzed epidemiologically. The frequency of visceral mycoses among the annual total number of pathological autopsy cases increased noticeably from 1.60% in 1969 to a peak of 4.66% in 1990. Among them, the incidences of candidiasis and aspergillosis increased the most. After 1990, however, the frequency of visceral mycoses decreased gradually. Until 1989, the predominant causative agent was Candida, followed in order by Aspergillus and Cryptococcus. Although the rate of candidiasis decreased by degrees from 1990, the rate of aspergillosis increased up to and then surpassed that of candidiasis in 1991. Leukemia was the major disease underlying the visceral mycoses, followed by solid cancers and other blood and hematopoietic system diseases. Severe mycotic infection has increased over the reported 25-year period, from 6.6% of the total visceral mycosis cases in 1969 to 71% in 1994. The reasons for this decrease of candidiasis combined with an increase of aspergillosis or of severe mycotic infection might be that (i) nonsevere (not disseminated) infections were excluded from the case totals, since they have become controllable by antifungal drugs such as fluconazole, but (ii) the available antifungal drugs were not efficacious against severe infections such as pulmonary aspergillosis, and (iii) the number of patients living longer in an immunocompromised state had increased because of developments in chemotherapy and progress in medical care.
APA, Harvard, Vancouver, ISO, and other styles
9

Ghitea, Timea Claudia, Simona Bungau, Delia Mirela Tit, et al. "The Effects of Oregano Oil on Fungal Infections Associated with Metabolic Syndrome." Revista de Chimie 71, no. 1 (2020): 335–41. http://dx.doi.org/10.37358/rc.20.1.7854.

Full text
Abstract:
This study aims to compare the evolution of mycosis associated with metabolic syndrome under allopathic treatment compared to phytotherapy using oregano essential oil. The study was conducted over a period of 6 months, on a total of 72 patients diagnosed with fungal infections associated with metabolic syndrome. The patients were divided into 3 groups, depending on the administered treatment: group 1: 24 patients who received allopathic treatment; group 2: 24 patients who received oregano oil treatment; group 3: control, which did not undergo any antifungal treatment. All three groups were subjected to specific diet therapy for mycosis. The patients were initially evaluated at 10 days after the begining of the treatment (to track mycotic disease evolution in the acute phase), at 60 days (to evaluate the recurrence of mycoses) and at 180 days to track recurrent disease. Most infections were acute (77.78%), the chronic ones representing only 5.56% of cases. There were also 12 cases with recurrent infections (16.67%), out of which 6 cases (8.33%) had previously shown resistance to Nystatin. In the 72 cases there was a sensitivity of 100.00% for oregano oil and Ketaconazolum, insignificantly higher than for Myconazolum (97.22%, p=0.157), but significantly higher than for Clotrimazolum and Nystatinum (94.44%, p=0.0437), Variconazole and Fluconazole (88.89%, p=0.0038) and Itraconazole (86.11%, p=0.0011). The results of this study showed an increased efficiency of oregano oil on the symptomatic and paraclinical improvement of mycotic infections in the study, both on short term and on long term, which was completed with high tolerability.
APA, Harvard, Vancouver, ISO, and other styles
10

Vdovina, L. V., N. V. Tiunova, S. M. Tolmacheva, and I. N. Usmanova. "Geotrlchous stomatitis in the dental practice." Endodontics Today 18, no. 2 (2020): 68–72. http://dx.doi.org/10.36377/1683-2981-2020-18-2-68-72.

Full text
Abstract:
A literature review was conducted on rare mycoses of the oral mucosa in patients with immunode^ciency conditions and hematologic malignant diseases, in particular, etiopathogenetic aspects, clinical features and an approach to the treatment of rare oral mycosis - geotrlchous stomatitis were examined.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Mycosis"

1

Fourel, Didier. "Manifestations viscérales extraganglionnaires du mycosis fongoi͏̈de et de la maladie de Sezary." Bordeaux 2, 1989. http://www.theses.fr/1989BOR25123.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Scarisbrick, Julia Jane. "Molecular genetics of mycosis fungoides and Sezary syndrome." Thesis, King's College London (University of London), 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.271821.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

COUSTAU, JEAN-YVES. "Traitement du mycosis fongoide : a propos de deux cas cliniques ; revue de la presse internationale." Toulouse 3, 1991. http://www.theses.fr/1991TOU31038.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

PERIA, PHILIPPE. "Le mycosis fongoide a plaque unique : a propos de trois observations." Angers, 1994. http://www.theses.fr/1994ANGE1080.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Modiano, Philippe. "Association mycosis fongoide et maladie de hodgkin : a propos de deux observations." Nancy 1, 1992. http://www.theses.fr/1992NAN11270.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Thaller, Eva. "Untersuchung zur Korrelation von Immunphänotyp und Klonalität bei Mycosis fungoides mittels Lasermikrodissektion." Diss., lmu, 2006. http://nbn-resolving.de/urn:nbn:de:bvb:19-52392.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Marcos, Elaine Valim Camarinha [UNESP]. "Doença de Jorge Lobo e sua relação com os antígenos do sistema HLA." Universidade Estadual Paulista (UNESP), 2001. http://hdl.handle.net/11449/89979.

Full text
Abstract:
Made available in DSpace on 2014-06-11T19:24:16Z (GMT). No. of bitstreams: 0 Previous issue date: 2001Bitstream added on 2014-06-13T18:52:01Z : No. of bitstreams: 1 marcos_evc_me_botfm.pdf: 520738 bytes, checksum: f88c3d4538478dc5809209838bf85c43 (MD5)
A doença de Jorge Lobo é uma micose causada pelo fungo Lacazia loboi (L.loboi), o qual se assemelha filogenética e antigenicamente ao Paracoccidioides brasiliensis (P.brasiliensis). Devido às características epidemiológicas e aos poucos estudos relacionados aos aspectos imunológicos dessa doença, o objetivo desse trabalho foi pesquisar a freqüência dos antígenos HLA de classe I e classe II em 21 pacientes portadores da doença de Jorge Lobo e comparar com população controle. As tipagens HLA de classe I foram realizadas pela técnica de microlinfocitotoxicidade e as de classe II pelo método de PCR-SSP. Como controles, utilizaram-se duas populações: uma do Estado do Acre e outra da população brasileira, segundo os dados publicados no 11th IHW no Japão. Esse trabalho sugere a primeira associação proposta entre antígenos e doença de Jorge Lobo, especificamente com o HLA-DQ3, quando comparados os dados entre pacientes e população brasileira. Contudo, não mostra qualquer tipo de associação quando se comparam pacientes e população do Acre. Acredita-se que, com o aumento do número de pacientes estudados e com a utilização de metodologia para identificação dos diferentes alelos que codificam o fenótipo DQ-3, poderão ser obtidos melhores resultados.
Jorge Lobo’s disease is a rare mycosis whose causative agent is the Lacazia loboi (L. loboi), a fungi antigenically and philogenetically similar to the Paracoccidioides brasiliensis (P. brasiliensis). Due to its epidemiological characteristics and the lack of studies related to the immunological aspects of this disease, our objective was to perform HLA class I and II typing in 21 Jorge Lobo’s disease patients and compare their frequency with the healthy population. The Class I HLA typing was done through the lymphotoxicity technique, and the class II HLA determined by the PCR-SSP method. Two control populations were used, one from the state of Acre and the Brazilian population data published at the 11 (IHW) in Japan. Our work suggests the first association proposed between antigen and Jorge Lobo’s disease, specifically the DQ3-HLA, when patients were compared with Brazilian population. However, no association could be demonstrated when patient were compared with the population from Acre. We believe that a larger sample and the use of a method for identification of phenotype DQ-3 encoding allele would give us more detailed results.
APA, Harvard, Vancouver, ISO, and other styles
8

Yamashita, Thamy [UNESP]. "Micose fungoide: diagnóstico nas fases iniciais através da correlação clínico-morfológica e imunoistoquímica das lesões." Universidade Estadual Paulista (UNESP), 2011. http://hdl.handle.net/11449/95882.

Full text
Abstract:
Made available in DSpace on 2014-06-11T19:27:56Z (GMT). No. of bitstreams: 0 Previous issue date: 2011-07-18Bitstream added on 2014-06-13T20:17:32Z : No. of bitstreams: 1 yamashita_t_me_botfm.pdf: 463756 bytes, checksum: 4914cf7ff50426b39858d09d75ace099 (MD5)
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
O diagnóstico preciso das lesões de micose fungoide (MF) em fases iniciais é difícil, pois uma variedade de doenças benignas se sobrepõem clínica e histologicamente. Foram selecionadas 101 biópsias que correspondiam a 67 pacientes cujas lesões se assemelhavam a MF clássica em fases iniciais, do período de 1999 a 2010, que estavam no arquivo do Departamento de Patologia da Faculdade de Medicina de Botucatu - Universidade Estadual Paulista. A proporção entre homens:mulheres foi de 2,6:1, com idades que variaram de 17 a 103 anos e idade média de 62,1 anos. O diagnóstico de MF foi confirmado pela correlação dos aspectos clínicos, histopatológicos e perfil imunoistoquímico. Os pacientes com diagnóstico de MF apresentaram-se com máculas e/ou placas correspondentes aos estágios T1 e T2, geralmente em áreas não expostas ao sol. Desses 67 pacientes analisados, 17 (25,5%) tiveram o diagnóstico de MF caracterizado pelos principais critérios histopatológicos: epidermotropismo desproporcional, microabscessos de Pautrier, alinhamento dos linfócitos e algum grau de atipia linfocitária. Em 3 (4,5%) dos pacientes cujo diagnóstico era MF, não apresentaram todos os principais critérios histopatológicos, porém o diagnóstico foi possível pela correlação com o perfil imunoistoquímico característico de CD3+, CD4+ e redução na expressão de CD8, CD7 e/ ou CD2 e CD5. Em 15 (22,5%) casos a suspeita para MF manteve-se, e, em 32 (47,5%) pacientes o diagnóstico de MF foi excluído e esses casos foram classificados como outras doenças. Portanto, mais de 47% dos pacientes foram falso-positivos se considerarmos apenas os aspectos clínicos. Embora o estudo imunoistoquímico seja uma importante técnica diagnóstica auxiliar, a maioria dos diagnósticos das lesões iniciais de MF dependem principalmente da correlação do histórico clínico e achados histopatológicos
Accurate diagnosis of early lesions of mycosis fungoides (MF) is difficult because of the varied clinical and histological patterns that may mimic other benign conditions. Data from 101 biopsies from 67 patients with lesions that seemed classical early MF registered between 1999 and 2010 were retrieved from the Department of Pathology at Botucatu Medical School - Sao Paulo State University. The male:female ratio = 2.6:1, age range17-103 years and mean age, 62.1 years. The diagnosis of MF was confirmed by correlation with clinical features, histopathology and immunohistochemistry technique. All MF patients presented patch and/or plaques corresponding the T1 and T2 disease staging, usually in non-exposed areas. Out of 67 patients analysed, 17 (25,5%) had the diagnosis of early MF histopathologically characterized by the main diagnostic criteria which are disproportionate epidermotropism, Pautrier’s microabscesses, linear arrangement distribution of lymphocytes and some degree of lymphocyte atypia. In 3 (4,5%) patients the diagnosis of MF did not have all the main histopathological criteria, but was also supported by CD3+, CD4+ and reduction of expression of CD8, CD7 and/ or CD2 and CD5, 15 (22,5%) cases remain suspicious for MF and 32 (47,5%) patients were ruled out as other diseases. Indeed, more than 47% were false positive for MF considering only the clinical aspects. Although immunohistochemistry may help, the majority of the diagnosis of early MF still rests upon clinical features and histopathological findings
APA, Harvard, Vancouver, ISO, and other styles
9

Marcos, Elaine Valim Camarinha. "Doença de Jorge Lobo e sua relação com os antígenos do sistema HLA /." Botucatu : [s.n.], 2001. http://hdl.handle.net/11449/89979.

Full text
Abstract:
Orientador: Diltor Vladimir Araujo Opromolla
Resumo: A doença de Jorge Lobo é uma micose causada pelo fungo Lacazia loboi (L.loboi), o qual se assemelha filogenética e antigenicamente ao Paracoccidioides brasiliensis (P.brasiliensis). Devido às características epidemiológicas e aos poucos estudos relacionados aos aspectos imunológicos dessa doença, o objetivo desse trabalho foi pesquisar a freqüência dos antígenos HLA de classe I e classe II em 21 pacientes portadores da doença de Jorge Lobo e comparar com população controle. As tipagens HLA de classe I foram realizadas pela técnica de microlinfocitotoxicidade e as de classe II pelo método de PCR-SSP. Como controles, utilizaram-se duas populações: uma do Estado do Acre e outra da população brasileira, segundo os dados publicados no 11th IHW no Japão. Esse trabalho sugere a primeira associação proposta entre antígenos e doença de Jorge Lobo, especificamente com o HLA-DQ3, quando comparados os dados entre pacientes e população brasileira. Contudo, não mostra qualquer tipo de associação quando se comparam pacientes e população do Acre. Acredita-se que, com o aumento do número de pacientes estudados e com a utilização de metodologia para identificação dos diferentes alelos que codificam o fenótipo DQ-3, poderão ser obtidos melhores resultados.
Abstract: Jorge Lobo's disease is a rare mycosis whose causative agent is the Lacazia loboi (L. loboi), a fungi antigenically and philogenetically similar to the Paracoccidioides brasiliensis (P. brasiliensis). Due to its epidemiological characteristics and the lack of studies related to the immunological aspects of this disease, our objective was to perform HLA class I and II typing in 21 Jorge Lobo's disease patients and compare their frequency with the healthy population. The Class I HLA typing was done through the lymphotoxicity technique, and the class II HLA determined by the PCR-SSP method. Two control populations were used, one from the state of Acre and the Brazilian population data published at the 11 (IHW) in Japan. Our work suggests the first association proposed between antigen and Jorge Lobo's disease, specifically the DQ3-HLA, when patients were compared with Brazilian population. However, no association could be demonstrated when patient were compared with the population from Acre. We believe that a larger sample and the use of a method for identification of phenotype DQ-3 encoding allele would give us more detailed results.
Mestre
APA, Harvard, Vancouver, ISO, and other styles
10

Carvalho, Fabiana Moura de. "Avaliação da associação sulfametoxazol-trimetropim no tratamento da paracoccidioidomicose experimental murina /." Botucatu : [s.n.], 2006. http://hdl.handle.net/11449/106361.

Full text
Abstract:
Orientador: Rinaldo Poncio Mendes
Banca: Eva Burger
Banca: Roberto Martinez
Resumo: O tratamento da PCM, micose sistêmica causada Paracoccidioides brasiliensis, continua sendo objeto de pesquisa clínica e experimental. Este trabalho avaliou a eficácia de diferentes esquemas terapêuticos com cotrimoxazol (CMX), na dose diária de 200 mg/kg de peso corporal, em dose diária única, no tratamento da PCM murina. Os resultados revelaram que o tratamento com CMX por tempo prolongado foi eficaz quando iniciado precoce ou tardiamente. O tratamento com curta duração foi ineficaz, pois não determinou diminuição da carga fúngica, durante as 20 semanas de seguimento. O efeito do CMX foi o mesmo em pulmões e baço, nos diferentes esquemas terapêuticos utilizados, eficazes ou não. A mortalidade cumulativa entre os grupos 1, 2 e 4 não diferiram entre si, os grupos 3 e 5 apresentaram a melhor taxa de sobrevida. Os níveis séricos de anticorpos específicos foram detectados a partir da segunda semana, apresentando maiores índices nos animais do G2, sendo que nesses os níveis aumentaram até a oitava semana e permanecendo estáveis por todo o experimento. No G3 houve uma flutuação durante todo o experimento apresentando níveis altos na 20a semana. Os grupos 4 e 5 permaneceram estáveis durante todo o experimento. Os efeitos benéficos do tratamento foram observados com a administração de CMX em dose única diária, cujos níveis séricos se mantiveram adequados por menos de 12 horas. Esses resultados, bastante satisfatórios, demonstram que o modelo experimental murino é bom método de avaliação da eficácia do CMX no tratamento da PCM e sugerem a avaliação de outros esquemas terapêuticos, como a administração a cada 12 horas.
Abstract: Paracoccidioidomicosis (PCM) treatment, a systemic mycosis caused by Paracoccidioides brasiliensis, has been a clinical and experimental research issue. This work evaluated the efficacy of different therapeutic protocols with cotrimoxazole (CMX) on a daily dosage of 200mg/kg body weight, in a single daily dosage on murine PCM treatment. The results showed that CMX treatment for a prolonged period was efficient when started early or late. The short duration treatment was inefficient once it did not determine fungus load decrease during 20 weeks of following. CMX effect was the same in lungs and spleen under different therapeutic protocols used, whether efficient or not. Cumulative death tends to be different among studied groups. Death frequency was smaller in prolonged treated groups with an early or late protocol starting. Specific antibodies blood levels were detected from the second week and did not differ among experimental groups. Beneficial effects of treatment were observed with CMX administration on a daily single dosage and blood levels remained satisfactory for less than 12 hours. These results, quite satisfactory, show that murine experimental protocol is a good evaluation method of MCX effectiveness on PCM treatment and it suggests the evaluation of other therapeutic protocols, as an administration at every 12 hours.
Doutor
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Mycosis"

1

Khan Mohammad Beigi, Pooya. Clinician's Guide to Mycosis Fungoides. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-47907-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

S, Zackheim Herschel, ed. Cutaneous T-cell lymphoma: Mycosis fungoides and Sézary syndrome. CRC Press, 2005.

APA, Harvard, Vancouver, ISO, and other styles
3

Beneke, E. S. Human mycoses. 8th ed. Upjohn Co., 1986.

APA, Harvard, Vancouver, ISO, and other styles
4

Presterl, Elisabeth, ed. Clinically Relevant Mycoses. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-92300-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Symposium on Topics in Mycology on Mycoses in AIDS Patients (1989 Paris, France). Mycoses in AIDS patients. Plenum Press, 1990.

APA, Harvard, Vancouver, ISO, and other styles
6

G, Braun Dietmar, and Koch Herbert A, eds. An atlas of mycoses. Grosse, 1988.

APA, Harvard, Vancouver, ISO, and other styles
7

Cutsem, J. Van. Mycoses in domestic animals. Janssen Research Foundation, 1991.

APA, Harvard, Vancouver, ISO, and other styles
8

Bossche, Hugo Vanden, Donald W. R. Mackenzie, Geert Cauwenbergh, Jan Van Cutsem, Edouard Drouhet, and Bertrand Dupont, eds. Mycoses in AIDS Patients. Springer US, 1990. http://dx.doi.org/10.1007/978-1-4613-0655-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

1964-, Lang Heidi, and Parish Lawrence Charles, eds. Manual of medical mycology. Blackwell Scientific, 1995.

APA, Harvard, Vancouver, ISO, and other styles
10

Tan, C. Shu-hui. Fungi that cause superficial mycoses. Centraalbureau voor Schimmelcultures, 1994.

APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Mycosis"

1

Nolting, Siegfried, and Klaus Fegeler. "Diseases Resembling Mycosis — Saphrophytic Mycoses." In Medical Mycology. Springer Berlin Heidelberg, 1987. http://dx.doi.org/10.1007/978-3-642-72553-1_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Mehlhorn, Heinz. "Mycosis." In Encyclopedia of Parasitology. Springer Berlin Heidelberg, 2016. http://dx.doi.org/10.1007/978-3-662-43978-4_4081.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Mehlhorn, Heinz. "Mycosis." In Encyclopedia of Parasitology. Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-642-27769-6_4081-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Hangay, George, Susan V. Gruner, F. W. Howard, et al. "Mycosis." In Encyclopedia of Entomology. Springer Netherlands, 2008. http://dx.doi.org/10.1007/978-1-4020-6359-6_4747.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Gooch, Jan W. "Mycosis." In Encyclopedic Dictionary of Polymers. Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4419-6247-8_14282.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Bensard, Denis D., Philip F. Stahel, Jorge Cerdá, et al. "Mycosis, Opportunistic." In Encyclopedia of Intensive Care Medicine. Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-00418-6_43.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Bensard, Denis D., Philip F. Stahel, Jorge Cerdá, et al. "Mycosis, Endemic." In Encyclopedia of Intensive Care Medicine. Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-00418-6_44.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Llewellyn, Moses. "Mycosis Fungoides." In When Doctors Get Sick. Springer US, 1988. http://dx.doi.org/10.1007/978-1-4899-2001-0_35.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Maibach, Howard. "Skin Mycosis." In Drug Discovery and Evaluation: Pharmacological Assays. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-05392-9_105.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Patel, Nisha R., Michael L. Wong, Anthony E. Dragun, et al. "Mycosis Fungoides." In Encyclopedia of Radiation Oncology. Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/978-3-540-85516-3_475.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Mycosis"

1

Hanaoka, K., Y. Onishi, R. Kagami, et al. "Real World Practice for Allergic Bronchopulmonary Mycosis (ABPM)." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2967.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Léger, C., E. Delandre, A. Durand, A. Chaupin-Prieur, and L. Caumette. "4CPS-032 Skin protection and prevention of cutaneous mycosis." In 24th EAHP Congress, 27th–29th March 2019, Barcelona, Spain. British Medical Journal Publishing Group, 2019. http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.181.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Ларина, Г. Е., Л. Г. Серая, С. А. Голимбовская, et al. "PHYTOPATHOLOGY (MYCOSIS) OF MEDICINAL PLANTS IN PERMANENT COLLECTION PLANTS." In 90 лет - от растения до лекарственного препарата: достижения и перспективы. Федеральное государственное бюджетное научное учреждение "Всероссийский научно-исследовательский институт лекарственных и ароматических растений", 2021. http://dx.doi.org/10.52101/9785870191003_2021_83.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Aisyah, P., F. F. Taufik, M. Elhidsi, and J. Zaini. "Coincidence of Lung Mycosis and Tuberculosis in Squamous Cell Carcinoma." In American Thoracic Society 2022 International Conference, May 13-18, 2022 - San Francisco, CA. American Thoracic Society, 2022. http://dx.doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a4543.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Sygaieva, Iryna. "Mycosis induced asthma treatment: fluticasone/salmeterol vs. budesonide/formoterol reinforced by montelukast." In ERS International Congress 2017 abstracts. European Respiratory Society, 2017. http://dx.doi.org/10.1183/1393003.congress-2017.pa4024.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Mohan, A., H. Iyer, `. Madan, et al. "Isolated Mediastinal Aspergillosis in an Immunocompetent Female: A Rare Cause of Pulmonary Mycosis." In American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a3972.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Wang, Kevin Y., Tao Wang, Yuehua Liu, and Christine Lian. "Abstract 220: Disease monitoring of mycosis fungoides via high throughput sequencing of CDR3." In Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7445.am2020-220.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Rendon-Serna, Natalia, Maeva Dufies, Luis Alfonso Correa-Londono, Olga Maria Bermudez-Munoz, Margarita Maria Velasquez-Lopera, and Gilles Pages. "Abstract 2650: Angiogenic inhibitors reduce mycosis fungoides cell survival and enhance cell death." In Proceedings: AACR Annual Meeting 2021; April 10-15, 2021 and May 17-21, 2021; Philadelphia, PA. American Association for Cancer Research, 2021. http://dx.doi.org/10.1158/1538-7445.am2021-2650.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Benzrath, Stefanie, Anne Schlegtendal, Folke Brinkmann, and Cordula Koerner-Rettberg. "Allergic bronchopulmonary mycosis due to rhizopus nigricans in two siblings with and without CF?" In ERS International Congress 2016 abstracts. European Respiratory Society, 2016. http://dx.doi.org/10.1183/13993003.congress-2016.pa1247.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Chen, Gwo-Hsiao, John J. Osterholzer, Michal A. Olszewski, et al. "INTERPLAY OF CD40-DEPENDENT AND INDEPENDENT MECHANISMS IN THE PATHOGENESIS OF MURINE ALLERGIC BRONCHOPULMONARY MYCOSIS." In American Thoracic Society 2010 International Conference, May 14-19, 2010 • New Orleans. American Thoracic Society, 2010. http://dx.doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a1808.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Mycosis"

1

Mateeva, Valeria, Doncho Etugov, and Grisha Mateev. Efficacy of Systemic PUVA (Psoralen Plus Ultraviolet Light-A) in Bulgarian Patients with Mycosis Fungoides. "Prof. Marin Drinov" Publishing House of Bulgarian Academy of Sciences, 2018. http://dx.doi.org/10.7546/crabs.2018.11.15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography